Vaccines and antibodies: our weapons against the coronavirus. The experimentation of the all-Italian anti Covid-19 vaccine has started, conceived by Takis Biotech of Castel Romano (Rome) and developed in collaboration with Rottapharm Biotech of Monza. A team work involving Sapienza University of Rome, the Lazio Region and the National Research Council.

UnitelmaSapienza talked about it with Giuseppe Roscilli, Director of the Department of Monoclonal Antibody Development at Takis Biotech; Beatrice Vallone, professor at the Department of Biochemical Sciences of Sapienza University of Rome and the Institute of Molecular Biology and Pathology of the CNR; Donatella Strangio, professor of Economic History at Sapienza University of Rome.

Interview by Roberto Sciarrone, Head of UnitelmaSapienza Press Office.